1 EXHIBIT 10.6 CLINICAL DEVELOPMENT AGREEMENT PROTOCOL #VIT-02-08961X AND PROTOCOL #VIT-03-08961X: Two Phase III Safety and Efficacy Studies of Vitrase(TM) (Hyaluronidase for Ophthalmic Intravitreal Injection) for Clearance of Severe Vitreous...Development Agreement • April 5th, 2000 • Ista Pharmaceuticals Inc • New Jersey
Contract Type FiledApril 5th, 2000 Company Jurisdiction
EXHIBIT 10.21 [LETTERHEAD OF ITC APPEARS HERE] Joint Research and Development Agreement This Agreement (the "Agreement") is made as of Oct 28, 1996 (the "Effective Date") by and between Exigent Diagnostics, Inc. ("Exigent"), a Delaware corporation...Development Agreement • March 8th, 1999 • Careside Inc • Surgical & medical instruments & apparatus • Pennsylvania
Contract Type FiledMarch 8th, 1999 Company Industry Jurisdiction
Confidential treatment has been requested for portions of this exhibit. The confidential portions are designated by brackets [ ]. CLINICAL DEVELOPMENT AGREEMENT (this "Agreement") between VION PHARMACEUTICALS INC.("The Sponsor") FOUR SCIENCE PARK NEW...Development Agreement • August 14th, 1997 • Vion Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Contract Type FiledAugust 14th, 1997 Company Industry
DEVELOPMENT AGREEMENT NO. 35-003-96 CALL HANDLINGDevelopment Agreement • November 14th, 1996 • Carnegie Group Inc • Services-computer processing & data preparation
Contract Type FiledNovember 14th, 1996 Company Industry